Table of Content

1 Market Overview
1.1 Montelukast Drug Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Montelukast Drug Market Size & Forecast
1.4.1 Global Montelukast Drug Revenue (2018 VS 2022 VS 2029)
1.4.2 Global Montelukast Drug Revenue in Value (2018-2029)
1.5 Market Drivers, Restraints and Trends
1.5.1 Montelukast Drug Market Drivers
1.5.2 Montelukast Drug Market Restraints
1.5.3 Montelukast Drug Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Merck & Co.
2.1.1 Business Overview
2.1.2 Merck & Co. SWOT Analysis
2.1.3 Merck & Co. Montelukast Drug Products and Service Offered
2.1.4 Merck & Co. Montelukast Drug Revenue and Gross Margin
2.2 Teva
2.2.1 Business Overview
2.2.2 Teva SWOT Analysis
2.2.3 Teva Montelukast Drug Products and Service Offered
2.2.4 Teva Montelukast Drug Revenue and Gross Margin
2.3 Mylan
2.3.1 Business Overview
2.3.2 Mylan SWOT Analysis
2.3.3 Mylan Montelukast Drug Products and Service Offered
2.3.4 Mylan Montelukast Drug Revenue and Gross Margin
2.4 Glenmark Pharmaceuticals
2.4.1 Business Overview
2.4.2 Glenmark Pharmaceuticals SWOT Analysis
2.4.3 Glenmark Pharmaceuticals Montelukast Drug Products and Service Offered
2.4.4 Glenmark Pharmaceuticals Montelukast Drug Revenue and Gross Margin
2.5 Hikma Group
2.5.1 Business Overview
2.5.2 Hikma Group SWOT Analysis
2.5.3 Hikma Group Montelukast Drug Products and Service Offered
2.5.4 Hikma Group Montelukast Drug Revenue and Gross Margin
2.6 Sandoz
2.6.1 Business Overview
2.6.2 Sandoz SWOT Analysis
2.6.3 Sandoz Montelukast Drug Products and Service Offered
2.6.4 Sandoz Montelukast Drug Revenue and Gross Margin
2.7 Torrent Pharmaceuticals
2.7.1 Business Overview
2.7.2 Torrent Pharmaceuticals SWOT Analysis
2.7.3 Torrent Pharmaceuticals Montelukast Drug Products and Service Offered
2.7.4 Torrent Pharmaceuticals Montelukast Drug Revenue and Gross Margin
2.8 Lannett Company
2.8.1 Business Overview
2.8.2 Lannett Company SWOT Analysis
2.8.3 Lannett Company Montelukast Drug Products and Service Offered
2.8.4 Lannett Company Montelukast Drug Revenue and Gross Margin
2.9 Apotex
2.9.1 Business Overview
2.9.2 Apotex SWOT Analysis
2.9.3 Apotex Montelukast Drug Products and Service Offered
2.9.4 Apotex Montelukast Drug Revenue and Gross Margin
2.10 Dr. Reddys Laboratories
2.10.1 Business Overview
2.10.2 Dr. Reddys Laboratories SWOT Analysis
2.10.3 Dr. Reddys Laboratories Montelukast Drug Products and Service Offered
2.10.4 Dr. Reddys Laboratories Montelukast Drug Revenue and Gross Margin
2.11 Aurobindo Pharma
2.11.1 Business Overview
2.11.2 Aurobindo Pharma SWOT Analysis
2.11.3 Aurobindo Pharma Montelukast Drug Products and Service Offered
2.11.4 Aurobindo Pharma Montelukast Drug Revenue and Gross Margin
2.12 Accord Healthcare
2.12.1 Business Overview
2.12.2 Accord Healthcare SWOT Analysis
2.12.3 Accord Healthcare Montelukast Drug Products and Service Offered
2.12.4 Accord Healthcare Montelukast Drug Revenue and Gross Margin
2.13 Hetero
2.13.1 Business Overview
2.13.2 Hetero SWOT Analysis
2.13.3 Hetero Montelukast Drug Products and Service Offered
2.13.4 Hetero Montelukast Drug Revenue and Gross Margin
2.14 Unimark
2.14.1 Business Overview
2.14.2 Unimark SWOT Analysis
2.14.3 Unimark Montelukast Drug Products and Service Offered
2.14.4 Unimark Montelukast Drug Revenue and Gross Margin
2.15 Ajanta Pharma
2.15.1 Business Overview
2.15.2 Ajanta Pharma SWOT Analysis
2.15.3 Ajanta Pharma Montelukast Drug Products and Service Offered
2.15.4 Ajanta Pharma Montelukast Drug Revenue and Gross Margin
2.16 MACLEODS
2.16.1 Business Overview
2.16.2 MACLEODS SWOT Analysis
2.16.3 MACLEODS Montelukast Drug Products and Service Offered
2.16.4 MACLEODS Montelukast Drug Revenue and Gross Margin
2.17 Jubilant Pharma
2.17.1 Business Overview
2.17.2 Jubilant Pharma SWOT Analysis
2.17.3 Jubilant Pharma Montelukast Drug Products and Service Offered
2.17.4 Jubilant Pharma Montelukast Drug Revenue and Gross Margin
2.18 Unichem Laboratories
2.18.1 Business Overview
2.18.2 Unichem Laboratories SWOT Analysis
2.18.3 Unichem Laboratories Montelukast Drug Products and Service Offered
2.18.4 Unichem Laboratories Montelukast Drug Revenue and Gross Margin
2.19 Amneal Pharmaceuticals
2.19.1 Business Overview
2.19.2 Amneal Pharmaceuticals SWOT Analysis
2.19.3 Amneal Pharmaceuticals Montelukast Drug Products and Service Offered
2.19.4 Amneal Pharmaceuticals Montelukast Drug Revenue and Gross Margin
2.20 Shanghai Anbison Lab
2.20.1 Business Overview
2.20.2 Shanghai Anbison Lab SWOT Analysis
2.20.3 Shanghai Anbison Lab Montelukast Drug Products and Service Offered
2.20.4 Shanghai Anbison Lab Montelukast Drug Revenue and Gross Margin
2.21 Perrigo
2.21.1 Business Overview
2.21.2 Perrigo SWOT Analysis
2.21.3 Perrigo Montelukast Drug Products and Service Offered
2.21.4 Perrigo Montelukast Drug Revenue and Gross Margin
2.22 Cipla
2.22.1 Business Overview
2.22.2 Cipla SWOT Analysis
2.22.3 Cipla Montelukast Drug Products and Service Offered
2.22.4 Cipla Montelukast Drug Revenue and Gross Margin
2.23 CSPC Ouyi Pharmaceutical
2.23.1 Business Overview
2.23.2 CSPC Ouyi Pharmaceutical SWOT Analysis
2.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Products and Service Offered
2.23.4 CSPC Ouyi Pharmaceutical Montelukast Drug Revenue and Gross Margin
3 Global Montelukast Drug Market Competition, by Manufacturer
3.1 Global Montelukast Drug Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Montelukast Drug Players Market Share in 2022
3.2.2 Top 6 Montelukast Drug Players Market Share in 2022
3.2.3 Market Competition Trend
3.3 Montelukast Drug Players Head Office, Business Provided
3.4 Montelukast Drug Mergers & Acquisitions
3.5 Montelukast Drug New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Montelukast Drug Revenue in Value by Type (2018-2029)
4.2 Global Montelukast Drug Revenue Share by Type (2018-2029)
5 Market Segment by Application
5.1 Global Montelukast Drug Revenue by Application (2018-2029)
5.2 Global Montelukast Drug Revenue Share by Application (2018-2029)
6 Global Montelukast Drug Market Analysis by Regions
6.1 Global Montelukast Drug Revenue and Market Share by Regions
6.1.1 Global Montelukast Drug Revenue by Regions (2018-2029)
6.1.2 Global Montelukast Drug Revenue Market Share by Regions (2018-2029)
6.2 North America Montelukast Drug Revenue and Growth (2018-2029)
6.3 Europe Montelukast Drug Revenue and Growth (2018-2029)
6.4 Asia Pacific Montelukast Drug Revenue and Growth (2018-2029)
6.5 South America Montelukast Drug Revenue and Growth (2018-2029)
6.6 Middle East and Africa Montelukast Drug Revenue and Growth (2018-2029)
7 North America Montelukast Drug by Country, by Type, and by Application
7.1 North America Montelukast Drug Revenue by Type (2018-2029)
7.2 North America Montelukast Drug Revenue by Application (2018-2029)
7.3 North America Montelukast Drug Revenue and Market Share by Countries
7.3.1 North America Montelukast Drug Revenue in Value by Country (2018-2029)
7.3.2 United States Montelukast Drug Revenue and Growth (2018-2029)
7.3.3 Canada Montelukast Drug Revenue and Growth (2018-2029)
7.3.4 Mexico Montelukast Drug Revenue and Growth (2018-2029)
7.4 North America SWOT Analysis
8 Europe Montelukast Drug by Country, by Type, and by Application
8.1 Europe Montelukast Drug Revenue by Type (2018-2029)
8.2 Europe Montelukast Drug Revenue by Application (2018-2029)
8.3 Europe Montelukast Drug Revenue and Market Share by Countries
8.3.1 Europe Montelukast Drug Revenue in Value by Country (2018-2029)
8.3.2 Germany Montelukast Drug Revenue and Growth (2018-2029)
8.3.3 France Montelukast Drug Revenue and Growth (2018-2029)
8.3.4 United Kingdom Montelukast Drug Revenue and Growth (2018-2029)
8.3.5 Russia Montelukast Drug Revenue and Growth (2018-2029)
8.3.6 Italy Montelukast Drug Revenue and Growth (2018-2029)
8.3.7 Nordic Montelukast Drug Revenue and Growth (2018-2029)
8.4 Europe SWOT Analysis
9 Asia Pacific Montelukast Drug by Country, by Type, and by Application
9.1 Asia Pacific Montelukast Drug Revenue by Type (2018-2029)
9.2 Asia Pacific Montelukast Drug Revenue by Application (2018-2029)
9.3 Asia Pacific Montelukast Drug Revenue and Market Share by Countries
9.3.1 Asia Pacific Montelukast Drug Revenue in Value by Country (2018-2029)
9.3.2 China Montelukast Drug Revenue and Growth (2018-2029)
9.3.3 Japan Montelukast Drug Revenue and Growth (2018-2029)
9.3.4 Korea Montelukast Drug Revenue and Growth (2018-2029)
9.3.5 India Montelukast Drug Revenue and Growth (2018-2029)
9.3.6 Southeast Asia Montelukast Drug Revenue and Growth (2018-2029)
9.3.7 Australia Montelukast Drug Revenue and Growth (2018-2029)
9.4 Asia Pacific SWOT Analysis
10 South America Montelukast Drug by Country, by Type, and by Application
10.1 South America Montelukast Drug Revenue by Type (2018-2029)
10.2 South America Montelukast Drug Revenue by Application (2018-2029)
10.3 South America Montelukast Drug Revenue and Market Share by Countries
10.3.1 South America Montelukast Drug Revenue in Value by Country (2018-2029)
10.3.2 Brazil Montelukast Drug Revenue and Growth (2018-2029)
10.3.3 Argentina Montelukast Drug Revenue and Growth (2018-2029)
10.4 South America SWOT Analysis
11 Middle East & Africa Montelukast Drug by Country, by Type, and by Application
11.1 Middle East & Africa Montelukast Drug Revenue by Type (2018-2029)
11.2 Middle East & Africa Montelukast Drug Revenue by Application (2018-2029)
11.3 Middle East & Africa Montelukast Drug Revenue and Market Share by Countries
11.3.1 Middle East & Africa Montelukast Drug Revenue in Value by Country (2018-2029)
11.3.2 Turkey Montelukast Drug Revenue and Growth (2018-2029)
11.3.3 Egypt Montelukast Drug Revenue and Growth (2018-2029)
11.3.4 Saudi Arabia Montelukast Drug Revenue and Growth (2018-2029)
11.3.5 UAE Montelukast Drug Revenue and Growth (2018-2029)
11.3.6 South Africa Montelukast Drug Revenue and Growth (2018-2029)
11.4 Middle East and Africa SWOT Analysis
12 Montelukast Drug Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Montelukast Drug Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer